Vergangene Veranstaltungen | |||||
Titel der Veranstaltung | Ort | Beginn |
|||
Impact of the Microbiome on Cancer Growth and Therapy | München | 15.02.2019 | |||
ITOC EDUCATION WORKSHOP 5 | Neapel | 26.11.2018 | |||
CDDF – Board Meeting CANCELLED | Neapel | 26.11.2018 | |||
3rd CDDF Multi-stakeholder workshop on Minimal Residual Disease (AML/CLL) | London | 08.11.2018 | |||
ITOC EDUCATION WORKSHOP 4 | München | 05.10.2018 | |||
CDDF Strategic Retreat | München | 05.10.2018 | |||
10. CDDF Alpine Conference | Buchen bei Telfs | 26.02.2018 | |||
6th ACCELERATE CONFERENCE 2018 | Brüssel | 08.02.2018 | |||
CDDF Multi-stakeholder workshop on Minimal Residual Disease | London, UK | 18.10.2017 | |||
CDDF Multi-stakeholder workshop – Access to Innovative Oncology Drugs in Europe | Madrid, Spanien | 07.09.2017 | |||
CDDF - Innovation in Oncology Clinical Trial Design | Frankfurt | 12.06.2017 | |||
CDDF Board Meeting | Brüssel | 27.04.2017 | |||
ACCELERATE – Paediatric Oncology Conference | Brüssel | 02.03.2017 | |||
CDDF 9th Alpine Conference | Innsbruck Buchen, Austria | 19.10.2016 | |||
CDDF Board Meeting | Podersdorf | 28.09.2016 | |||
CDDF – Workshop on Real World Data | London | 06.07.2016 | |||
CDDF Board Meeting | Prag | 12.05.2016 | |||
EMA – CDDF Joint Meeting: Challenges for the approval of anti-cancer immunotherapeutic drugs | London | 04.02.2016 | |||
CDDF – ITCC – SIOPE: 4th Paediatric Oncology Conference | Brüssel | 20.01.2016 | |||
IMMUNO BIOMARKER DEVELOPMENT IN THE PERIPHERAL BLOOD | Wien | 07.12.2015 | |||
CDDF Board Meeting | Brussels | 10.09.2015 | |||
CDDF Board Meeting April 2015 | Brussels | 08.04.2015 | |||
Immunotherapy of Cancer Conference - ITOC2 | München | 25.03.2015 | |||
CDDF 8th Alpine Conference | Telfs-Buchen / Innsbruck | 02.03.2015 | |||
CDDF 3rd Paediatric Oncology Conference | Wien | 05.02.2015 | |||
CDDF ITCC ENCCA SIOPE Paediatric Oncology Taskforce | Vienna | 04.02.2015 | |||
Biomarker Task Force | Brussels | 12.12.2014 | |||
CDDF Workshop - Companion Diagnostics | Brüssel | 11.12.2014 | |||
CDDF Board Meeting | Brussels | 19.09.2014 | |||
Minimal Residual Disease: End-Points in Clinical Trials | London | 13.05.2014 | |||
BDA Board Meeting | Brussels | 28.03.2014 | |||
Access to Innovative Oncology Medicines in Europe | Bonn | 16.01.2014 | |||
How to mature emerging technologies into companion diagnostics | Brussels | 12.12.2013 | |||
Improving oncology drugs development for children and adolescents | Paris | 18.11.2013 | |||
BDA – ECCO Joint Session during ECC 2013 | Amsterdam | 28.09.2013 | |||
BDA Board Meeting | Brussels | 13.09.2013 | |||
BDA Board Meeting | Podersdorf | 11.04.2013 | |||
Seventh Alpine Meeting - Meeting the Current and Future Challenges of Oncology Drug Development | Telfs-Buchen / Innsbruck | 25.03.2013 | |||
Immuno-Oncology putting theory into practice | Frankfurt | 28.01.2013 | |||
Present and future breast cancer management: bench to bedside and back | Wien | 29.11.2012 | |||
BDA Board Meeting | Podersdorf | 13.04.2012 | |||
BTOC 11 – Biological Therapy of Cancer | Munich | 14.03.2012 | |||
Pediatric Workshop 2011 | London | 05.12.2011 | |||
6th Alpine Meeting – Joint meeting between Academia, Industry, Regulators & Patient Advocacy Groups | Innsbruck | 04.10.2011 | |||
BDA Paediatric Oncology Planning Workshop | London | 17.05.2011 | |||
BDA Board Meeting, spring 2011 | Vienna | 18.03.2011 | |||
Actual developments in European Regulatory and HTA Management | Bonn, Germany | 09.03.2011 | |||
'Combination NME‘s in Oncology – Opportunities and Challenges' | Brussels | 07.12.2010 | |||
BDA Board Meeting | Podersdorf am See | 24.09.2010 | |||
10th International Symposium Biological Therapy of Cancer | Munich | 08.09.2010 | |||
BDA Board Meeting | Frankfurt | 09.04.2010 | |||
5th Alpine Meeting – Joint meeting between Academia, Industry, Regulators & Patient Advocacy Groups | Innsbruck | 03.03.2010 | |||
BDA Executive Workshop-Oncology Based Drug Development | Brussels | 09.02.2010 | |||
Proteomics in Clinical Oncology: Possibilities, Promise and Pitfalls | Berlin, Germany | 18.09.2009 | |||
Critical Success Factors for new oncology products | Brussels | 10.09.2009 | |||
congressinfo.net | Server Zeit: 14.12.2024 23:36 [CET, GMT +0100] |
© pdl-solutions 2007 - 2024 |